Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
30.2M
-
Number of holders
-
246
-
Total 13F shares, excl. options
-
10.6M
-
Shares change
-
+614K
-
Total reported value, excl. options
-
$981M
-
Value change
-
+$54.3M
-
Put/Call ratio
-
0.99
-
Number of buys
-
147
-
Number of sells
-
-105
-
Price
-
$92.23
Significant Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) as of Q2 2021
327 filings reported holding FLGT - Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share as of Q2 2021.
Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) has 246 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.6M shares
of 30.2M outstanding shares and own 35.2% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.06M shares), VANGUARD GROUP INC (1.28M shares), STATE STREET CORP (609K shares), BAKER BROS. ADVISORS LP (401K shares), MORGAN STANLEY (362K shares), GEODE CAPITAL MANAGEMENT, LLC (336K shares), JPMORGAN CHASE & CO (332K shares), Invesco Ltd. (299K shares), Nepsis, Inc. (205K shares), and Bank of New York Mellon Corp (193K shares).
This table shows the top 246 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.